Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a...
Day: August 20, 2025
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...
Option Care Health Announces Chief Financial Officer Transition
Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1,...
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic...
Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment
MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc.,...
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage...
Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market
JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today...
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical...
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and...
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory EnvironmentGLEN ALLEN, Va.,...
Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology
Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity...
Hemp Hop Launches 93% THCa Concentrate + 2 Exotic THCa Flowers
CHARLOTTE, N.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Hemp Hop, a trusted name in premium hemp products since 2018, has...
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D...
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
These recent LungFit PH international agreements bring the ex-U.S. total to 34 countries and a combined population of 2.7 billion...
BBOT to Participate in Upcoming September Investor Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical...
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- San Francisco Bay Area-based crop biotechnology firms genXtraits, Inc. (genXtraits) and Mendel...
OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data...
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE)...